Isogel (Ispaghula Husk)

Ispaghula husk is a soluble dietary fiber that absorbs water in the gut, forming a gel‑like mass. This mass enlarges the stool, stimulates stretch receptors in the colon, and enhances peristaltic activity, thereby facilitating smoother transit of feces through the intestines.

The appropriate dose of Isogel is determined by the prescribing healthcare professional based on the individual’s age, condition severity, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose without medical guidance.

Safety data for Ispaghula husk during pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should consult their physician before using Isogel to weigh potential benefits against any unknown risks.

To place an order, submit an enquiry on the Isogel product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Isogel belongs to the bulk‑forming laxative class, similar to psyllium or methylcellulose. Unlike stimulant laxatives, it works locally by adding fiber and water to stool, offering a gentler, non‑systemic option with a lower risk of electrolyte imbalance, making it suitable for long‑term use under medical supervision.

Isogel should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the product from moisture, excessive heat, and direct sunlight to maintain its efficacy and prevent clumping of the fiber.

Isogel is taken orally, typically mixed with a full glass of water or another suitable fluid. The mixture should be consumed immediately after preparation to ensure the fiber expands properly and provides the intended laxative effect.

Serious risks, though uncommon, include intestinal obstruction or impaction, severe abdominal pain, allergic reactions such as rash or swelling, and rectal bleeding. Patients experiencing any of these symptoms should discontinue use and seek medical attention promptly.

Isogel is contraindicated in individuals with known or suspected bowel obstruction, severe constipation, chronic intestinal diseases that impair motility, or a documented hypersensitivity to Ispaghula husk or any excipients. Consultation with a healthcare provider is essential before starting therapy.